StandardAero amends 8-K to correct Q2 operating cash flow wording to $72.3 million provided by operations
Reuters2026/08/07 10:30- StandardAero filed an amended 8-K to correct a cash flow error in its Aug. 6 earnings release for Q2 ended June 30, 2026.
- Cash flow from operations was misstated as a $72.3 million use of cash; the corrected figure was $72.3 million provided by operations.
- A summary table line item was revised to “net cash provided by (used in) operating activities” to reflect the positive operating cash flow.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Cambria Gold Mines FY26 Q2 net loss narrows to CAD 2.96 million
TRUMP rises nearly 8% in 24 hours, market capitalization reaches $2.037 billions
Electra Therapeutics (ETRA.US) submits US IPO application, leveraging the biotech IPO boom to advance new drug development for immune diseases and cancer.
Electra Therapeutics Inc. has officially filed for an initial public offering (IPO), aiming to leverage the strong IPO performance of the biotechnology sector this year to raise funds for its clinical-stage pipeline of drugs targeting immune-mediated diseases and cancer.
Crypto prices
More
